SPRO
Spero Therapeutics Inc.
Company Overview
| Mkt Cap | $133.94M | Price | $2.43 |
| Volume | 493.27K | Change | +2.97% |
| P/E Ratio | -2.0 | Open | $2.35 |
| Revenue | $371.0K | Prev Close | $2.36 |
| Net Income | $-68.6M | 52W Range | $0.51 - $3.22 |
| Div Yield | N/A | Target | $5.00 |
| Overall | 60 | Value | 55 |
| Quality | -- | Technical | 66 |
No chart data available
Stock Overview
Updated DailySpero Therapeutics Inc. (SPRO) is a leading Healthcare company in the Biotechnology industry, currently trading at $2.43 with a market capitalization of $133.94 million. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows SPRO with a volume of 493K shares. The stock opened down 0.42% from yesterday's close of $2.36. Current analyst estimates project earnings of $-0.79 per share for this year, with next year targeting $-0.74.
SPRO demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including FC, LTRE, IBM, NAUH, DV.
Key investment considerations for SPRO include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 105.8%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 2, 2025 at 08:42 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SPRO | $2.43 | +3.0% | 493.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |